114 related articles for article (PubMed ID: 20565293)
1. The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection.
Droebner K; Klein B; Paxian S; Schmid R; Stitz L; Planz O
Viral Immunol; 2010 Jun; 23(3):295-308. PubMed ID: 20565293
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
3. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
[TBL] [Abstract][Full Text] [Related]
4. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
[TBL] [Abstract][Full Text] [Related]
5. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
7. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
[TBL] [Abstract][Full Text] [Related]
9. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways.
Johnson DM; Khakhum N; Wang M; Warner NL; Jokinen JD; Comer JE; Lukashevich IS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675975
[TBL] [Abstract][Full Text] [Related]
11. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
Thomsen AR; Volkert M; Marker O
Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
Holst PJ; Christensen JP; Thomsen AR
J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
[TBL] [Abstract][Full Text] [Related]
13. Too much of a good thing: Sustained type 1 interferon signaling limits humoral responses to secondary viral infection.
Teijaro JR
Eur J Immunol; 2016 Feb; 46(2):300-2. PubMed ID: 26783074
[TBL] [Abstract][Full Text] [Related]
14. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
Molina TJ; Bachmann MF; Kündig TM; Zinkernagel RM; Mak TW
J Immunol; 1993 Jul; 151(2):699-706. PubMed ID: 8393038
[TBL] [Abstract][Full Text] [Related]
16. A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
Le Bon A; Montoya M; Edwards MJ; Thompson C; Burke SA; Ashton M; Lo D; Tough DF; Borrow P
Eur J Immunol; 2006 Aug; 36(8):2085-93. PubMed ID: 16810633
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice.
Li W; Hofer MJ; Noçon AL; Manders P; Campbell IL
Virology; 2013 May; 439(2):152-62. PubMed ID: 23490048
[TBL] [Abstract][Full Text] [Related]
18. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
19. Immunity to lymphocytic choriomeningitis virus in B cell-depleted mice: evidence for B cell and antibody-independent protection by memory T cells.
Cerny A; Huegin AW; Sutter S; Bazin H; Hengartner HH; Zinkernagel RM
Eur J Immunol; 1986 Aug; 16(8):913-7. PubMed ID: 3488911
[TBL] [Abstract][Full Text] [Related]
20. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
